A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection

Abstract Monkeypox virus (MPXV) has re-emerged globally since May 2022, posing a significant public health threat. To address this, we develop two multivalent mRNA vaccine candidates—AAL, encoding three MPXV antigens, and AALI, which combines AAL with an immune-enhancing IFN-α protein. Both vaccines...

Full description

Saved in:
Bibliographic Details
Main Authors: Yansheng Li, Lin Cheng, Lixu Jiang, Zhuohuan Li, Jing Rao, Tong Wu, Fangyan Zhang, Baocai Xie, Yu He, Lianrong Wang, Zheng Zhang, Shi Chen
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-61699-w
Tags: Add Tag
No Tags, Be the first to tag this record!